Skip to main content

7 Result(s)

within JH Antin Remove this filter Medicine & Public Health Remove this filter

and

  1. No Access

    Article

    A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation

    Interleukin-11 (IL-11) decreases cytokine release and increases survival in murine BMT models. In these systems, it reduces gut permeability, partially polarizes T cells to a Th2 phenotype, down-regulates IL-1...

    JH Antin, SJ Lee, D Neuberg, E Alyea, RJ Soiffer, S Sonis… in Bone Marrow Transplantation (2002)

  2. No Access

    Article

    A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation

    Intravenous immunoglobulin is approved for use in allogeneic bone marrow transplant recipients for prevention of graft-versus-host disease (GVHD) and infections, but the minimally effective dose has not been e...

    DJ Winston, JH Antin, SN Wolff, BE Bierer, T Small… in Bone Marrow Transplantation (2001)

  3. No Access

    Article

    Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation

    Antibody concentrations to vaccine-preventable diseases decline following BMT and an optimal schedule for vaccination after transplant has not been established. We examined antibody responses to tetanus toxoid...

    E Vance, S George, EC Guinan, C Wheeler, JH Antin… in Bone Marrow Transplantation (1998)

  4. No Access

    Article

    Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia

    Therapy-related myelodysplasia (MDS) is a fatal marrow disorder distinct from primary MDS. We examined the efficacy of bone marrow transplantation (BMT) as a treatment for patients with therapy-related MDS. Ei...

    KK Ballen, DG Gilliland, EC Guinan, C-C Hsieh, SK Parsons… in Bone Marrow Transplantation (1997)

  5. No Access

    Article

    Energy level and sleep quality following bone marrow transplantation

    While problems with sleep and energy level (ie fatigue) are commonly reported during recovery from bone marrow transplantation (BMT), little in-depth information regarding these two problem areas in BMT patien...

    MA Andrykowski, JS Carpenter, CB Greiner, EM Altmaier… in Bone Marrow Transplantation (1997)

  6. No Access

    Article

    Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT)

    Accelerated granulocyte and platelet recovery following peripheral blood stem cell transplantation (PBSCT) are well documented. We hypothesize that functional immunity may also be enhanced in PBSCT and perform...

    CY Chan, DC Molrine, JH Antin, C Wheeler, EC Guinan… in Bone Marrow Transplantation (1997)

  7. No Access

    Article

    Idiopathic thrombocytopenic purpura following allogeneic bone marrow transplantation – treatment with anti-D immunoglobulin

    A 38-year-old man developed idiopathic thrombocytopenic purpura (ITP) 8 months following allogeneic BMT while being treated for cGVHD with corticosteroids and tacrolimus (FK506). He received two courses of hig...

    SJ Lee, W Hallowell Churchill, A Konugres, DG Gilliland… in Bone Marrow Transplantation (1997)